Institute of Medicine Criteria (2015)

The Institute of Medicine (now National Academy of Medicine) published diagnostic criteria in 2015 following a comprehensive systematic review (Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2015). The IOM report proposed renaming the condition “Systemic Exertion Intolerance Disease” (SEID) to emphasize the central role of post-exertional malaise and to move away from the stigmatizing “chronic fatigue” label — a concern later validated experimentally: the CFS label generates more negative attributions than “myalgic encephalopathy” (n=143) (Jason et al. 2002). However, the SEID terminology has seen limited clinical adoption.

1 Required Core Symptoms

ImportantRequirement: IOM Diagnostic Algorithm

Diagnosis requires ALL THREE of the following core symptoms to be present:

1. Substantial Reduction or Impairment in Activity Level (MANDATORY)

A substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, educational, social, or personal activities that:

  • Persists for more than 6 months
  • Is accompanied by fatigue (often profound)
  • Is of new or definite onset (not lifelong)
  • Is not the result of ongoing excessive exertion
  • Is not substantially alleviated by rest

2. Post-Exertional Malaise (PEM) — MANDATORY

Worsening of symptoms following physical, cognitive, or emotional exertion that would not have caused a problem before illness. Characteristics include:

  • Symptoms typically worsen 12–48 hours after activity
  • Often leads to relapse lasting days, weeks, or longer
  • Exertion threshold for triggering symptoms is low
  • Recovery is prolonged

The IOM emphasizes that PEM is the hallmark symptom that distinguishes ME/CFS from other fatiguing conditions.

3. Unrefreshing Sleep (MANDATORY)

Patients wake feeling unrefreshed regardless of sleep duration. Sleep may be:

  • Disrupted (frequent awakenings, difficulty initiating sleep)
  • Prolonged (hypersomnia with no restoration)
  • Reversed sleep/wake cycle

The exhaustion persists despite adequate sleep duration.

2 Additional Required Symptoms

ImportantRequirement: At Least ONE of the Following

Cognitive Impairment Problems with thinking, memory, information processing, or executive function. May include:

  • Difficulty finding words, storing and retrieving information
  • Slowed processing speed
  • Inability to focus or multitask
  • Problems with short-term memory

Cognitive symptoms may worsen with physical or mental exertion, emotional stress, or time pressure.

OR

Orthostatic Intolerance Worsening of symptoms upon assuming or maintaining upright posture. May include:

  • Lightheadedness, dizziness, fainting
  • Worsening fatigue or cognitive impairment when upright
  • Palpitations, nausea
  • Symptoms improve (but may not resolve) when lying down

Objective findings may include abnormal heart rate or blood pressure responses during tilt table testing or standing test.

3 Diagnostic Algorithm Structure

The IOM criteria can be formalized as a logical algorithm:

\[ \text{ME/CFS}_{\text{IOM}} = cases( \text{Substantial Activity Reduction} \wedge, \text{Post-Exertional Malaise} \wedge, \text{Unrefreshing Sleep} \wedge, (\text{Cognitive Impairment} \vee \text{Orthostatic Intolerance}) \wedge, \text{Duration} \geq 6 \text{months} \wedge, \text{Exclusions ruled out}, ) \]

This represents a minimal sufficient set: three universal core features plus at least one of two common manifestations.

4 Exclusions and Comorbidities

  • Exclusions: Medical conditions that could fully explain the symptoms must be ruled out through appropriate testing (hypothyroidism, anemia, sleep apnea, etc.)
  • Comorbidities allowed: Fibromyalgia, irritable bowel syndrome, depression, and anxiety frequently co-occur and do not exclude ME/CFS diagnosis
  • Important distinction: Comorbid depression is reactive (consequence of severe disability) rather than causative

5 Strengths and Limitations

The IOM criteria offer several advantages:

  • Simplicity: Four required features (3 core + 1 of 2 additional) make diagnosis straightforward
  • High sensitivity: Captures broader range of ME/CFS patients than ICC or Canadian Consensus
  • Evidence-based: Derived from systematic review identifying most discriminating symptoms
  • PEM emphasis: Recognizes post-exertional malaise as the pathognomonic feature
  • Clinical practicality: Feasible in primary care settings without extensive symptom checklists
  • Rapid assessment: Can be evaluated in a standard office visit
CautionWarning: IOM Limitations

The simplified structure creates potential issues:

  • Reduced specificity: More inclusive criteria may capture patients with other conditions (long COVID, post-viral fatigue that will resolve)
  • Heterogeneity: Broader patient population increases phenotypic variance in research cohorts
  • Cognitive OR orthostatic requirement: Patients may meet criteria with only one of these domains, potentially missing multi-system nature
  • SEID terminology rejected: Proposed name change has not gained acceptance in patient or research communities
  • Set-theoretic relationship: \(\text{ICC} \subset \text{Canadian} \subset \text{IOM}\) — IOM captures the broadest population

6 Clinical and Research Application

For clinical diagnosis: The IOM criteria are excellent for primary care and general practice:

  • Simple enough for non-specialists to apply
  • High sensitivity ensures few false negatives
  • Enables early diagnosis and intervention

For research: The IOM criteria are appropriate when:

  • Study aims to represent the full ME/CFS population
  • Recruitment needs to be pragmatic and efficient
  • Results should generalize to clinical settings

Not optimal for: Mechanistic research or treatment trials requiring homogeneous cohorts (use ICC or Canadian Consensus with biomarker stratification instead).

References

Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 2015. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: National Academies Press. https://doi.org/10.17226/19012.
Jason, Leonard A, Renee R Taylor, Sigita Plioplys, Zuzana Stepanek, and Jennifer Shlaes. 2002. “Evaluating Attributions for an Illness Based Upon the Name: Chronic Fatigue Syndrome, Myalgic Encephalopathy and Florence Nightingale Disease.” American Journal of Community Psychology 30 (1): 133–48. https://doi.org/10.1023/A:1014328319297.